A Finnish study linked protein sources with small testosterone differences. Understand the findings, study limits and why they do not change clinical care.
On October 30, 2026, Euronews reported on a University of Eastern Finland study comparing dietary protein sources with blood testosterone measurements in middle-aged men. Its English and Spanish coverage described findings from the Kuopio Ischaemic Heart Disease Risk Factor Study.
This article is for informational purposes only and is not medical advice. Questions about symptoms, hormone testing or treatment should be discussed with a qualified clinician.
The analysis involved 2,546 men aged 42 to 60 who lived in eastern Finland. According to the Euronews report, researchers used four-day dietary records collected between 1984 and 1989. Blood samples provided measurements of total testosterone and sex hormone-binding globulin, or SHBG.
SHBG is a protein that influences the amount of testosterone measured in blood. Including it gave the researchers another hormone-related measurement to compare with reported protein intake.
The team divided participants into four groups according to protein intake. It then examined how average hormone measurements differed across those groups. The analyses accounted for age, body mass index and several other dietary, lifestyle and health-related factors.
The central question concerned the relationship between protein sources and measured hormone levels. The researchers examined broad animal-protein and plant-protein categories as well as more specific food sources.
Euronews reported different directions of association for the broad protein categories:
Each figure compares the highest group with the lowest group within its own protein category. The animal-protein comparison and the plant-protein comparison therefore describe separate groupings based on intake.
The figures belong to those comparisons. They describe average hormone levels across dietary groups rather than a testosterone change assigned to a serving of a particular food.
The more detailed results were not simply an animal-versus-plant split. According to the report, the associations differed by protein source:
The distinction between dairy and meat is particularly important. Both sit under the broad animal-protein label, yet their reported relationships with total testosterone were different. The meat-protein finding concerned SHBG instead.
On the plant side, the result highlighted protein from vegetables and non-cereal sources. Describing that only as a finding about greens would leave out part of the reported category. Treating every plant food as interchangeable would also lose the distinction made in the analysis.
These details help preserve the actual finding when it is shortened into a headline. “Animal protein” and “plant protein” summarize broad categories, but the source-specific results give a more precise account of what the researchers observed.
For background on the measurements themselves, Testostra’s explanation of how related hormone markers fit together provides context for the laboratory terminology.
This was a cross-sectional observational study. Researchers compared dietary records with hormone measurements rather than assigning participants to different diets and tracking a response.
That design cannot establish that animal protein lowered testosterone or that plant protein raised it. Accounting for measured factors does not turn the comparison into an experiment. The researchers noted that other aspects of diet or metabolic factors could be related to the associations.
Euronews’ Spanish-language report also emphasized this distinction. The findings do not show that switching to a plant-based diet raises testosterone.
According to the coverage, doctoral researcher Miika Wynne-Ellis characterized the differences as statistically significant but relatively small. The study could not establish whether they mattered for health.
That distinction is central to interpreting the numbers. A measurable difference between group averages is not the same as a demonstrated improvement in health. The description “statistically significant” should therefore be read alongside the researchers’ caution about unknown health implications.
The direction of an association alone does not resolve that question. A higher average testosterone measurement is a laboratory finding here, not evidence that the men in that group had better health.
The study population consisted of middle-aged men living in eastern Finland. Its results should not automatically be extended to younger men, older men or populations with different dietary patterns.
The timing of the records also matters. These were dietary records from 1984 to 1989 rather than a survey of present-day eating habits. The four-day recording window provides a defined view of reported intake, not a complete account of each participant’s diet over the years.
Those features define the setting in which the associations were observed. They are relevant when deciding how broadly to apply the findings beyond this particular group.
The reported hormone associations concerned total testosterone and SHBG. They do not establish that a protein source treats symptoms or improves clinical outcomes.
The study also could not determine whether different protein sources affected testosterone production or its effects in the body. A biological explanation should not be assumed simply because the group averages differed.
Taken together, these limits place the result in the category of a dietary-pattern signal worth further research. They do not support a food-based treatment for suspected low testosterone.
This finding should not immediately change medical practice. It adds a research question about protein sources and hormone measurements rather than a new clinical rule about what men should eat.
There is no basis in these results for diagnosing low testosterone from someone’s protein preferences or choosing hormone treatment around those preferences. Personal decisions about symptoms, testing and treatment belong with qualified clinical care.
For a man concerned about possible low testosterone, the useful distinction is between the dietary headline and the reason for seeking medical review. A clinical conversation can focus on the symptoms themselves and what assessment is appropriate. The study’s group averages are background information for that discussion rather than its answer.
Testostra’s guide to understanding low testosterone assessment addresses that clinical question more directly. Its overview of preparing for a medical evaluation offers further context for discussing concerns with a clinician.
The practical takeaway is not to build a testosterone-focused menu from these numbers. It is to keep the finding in its proper role: an observation that may help shape future research. Individual symptom assessment and treatment decisions remain separate from this comparison of dietary groups.
Deciding how much weight to give a protein-and-testosterone headline is where Testostra’s educational role begins. For men uncertain about possible low testosterone symptoms and their causes, its research-led explanations provide context for understanding hormone findings while leaving personal assessment and treatment to qualified clinicians.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra